Michelle Sullivan Bruzatori, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 2037 W Main St, Cabot, AR 72023 Phone: 501-843-4555 |
Anne Meredith Brown, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 205 Westport Dr, Cabot, AR 72023 Phone: 501-843-6585 |
Ms. Christina M Reid, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 205 Westport Dr, Suite 1, Cabot, AR 72023 Phone: 501-843-6585 Fax: 501-843-2380 |
Brooke Marie Guillo, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 2037 W Main St, Cabot, AR 72023 Phone: 501-843-4555 |
Katie Janette Carillon, P.A.C. Physician Assistant - Medical Medicare: Accepting Medicare Assignments Practice Location: 2037 W Main St, Cabot, AR 72023 Phone: 501-843-4555 Fax: 501-743-1550 |
Daniel David Ring, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 205 Westport Dr Ste 1, Cabot, AR 72023 Phone: 501-843-6585 Fax: 501-843-2380 |
Angela E Eichhorn, PA-C Physician Assistant - Medical Medicare: Medicare Enrolled Practice Location: 2037 W Main St, Cabot, AR 72023 Phone: 501-843-4555 |
Zoe Dehart Boshears, Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 26 Turnberry Dr, Cabot, AR 72023 Phone: 501-764-8474 |
News Archive
BioMarin Pharmaceutical Inc. announced today that it has initiated a Phase 1/2 trial for BMN 701, a novel fusion protein of insulin-like growth factor 2 and acid alpha glucosidase in development for the treatment of Pompe disease.
AIDS Healthcare Foundation (AHF) today praised the action taken by thirty-eight members of the California Assembly who, in a signed letter, urged Governor Schwarzenegger to protect funding for California's AIDS Drug Assistance Program (ADAP). The Governor, who is currently completing his 2010-11 budget, could propose up to $70 million in cuts to ADAP in his upcoming budget, a move which, if enacted, will gut the state's lifesaving AIDS drug program currently serving more than 35,000 low-income Californians living with HIV/AIDS.
Researchers at UT Southwestern Medical Center have found an enzyme vital for controlling the early stages of cell death - a beneficial and normal process when it works right, but malignant in a variety of cancers when it malfunctions.
Reducing sodium intake is a major public health priority that must be acted upon by governments and nongovernmental organizations to improve population health, states an article http://www.cmaj.ca/press/cmaj090361.pdf in CMAJ (Canadian Medical Association Journal) www.cmaj.ca.
ChemGenex Pharmaceuticals Limited and Hospira, Inc. announced today that they have entered into an exclusive agreement to license, develop and commercialize ChemGenex's product candidate omacetaxine mepesuccinate, a novel targeted cytotoxic pharmaceutical product, in Europe, the Middle East and parts of Africa (the Territory).
› Verified 4 days ago